US20040110763A1
(en )
2004-06-10
Pyrazolopyridine compound and pharmaceutical use thereof
JP5422783B2
(ja )
2014-02-19
Pi3キナーゼ阻害剤として使用するキナゾリン−4(3h)−オン誘導体
JP2005508313A5
(enExample )
2005-12-22
TW200300141A
(en )
2003-05-16
Organic compounds
MX2008011369A
(es )
2008-09-18
Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2.
WO2005021515A3
(en )
2005-08-25
Inhibitors of phosphodiesterase type-iv
WO2006064355A3
(en )
2006-08-03
Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
TNSN07251A1
(en )
2008-12-31
2-phenyl-indoles as prostaglandin d2 receptor antagonists
TWI262920B
(en )
2006-10-01
New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
JP2008519794A5
(enExample )
2008-12-25
JP2005516067A5
(enExample )
2006-03-23
JP2010155827A5
(enExample )
2013-01-17
WO2006018718A3
(en )
2006-05-04
Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
HRP20151338T1
(hr )
2016-01-15
[4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoksi-etil)-4trifluorometoksi-1h-indol-3-il]metanon kao inhibitor triptaze mastocita
NO20071193L
(no )
2004-08-24
Fluorsubstituerte sykloalkanoindoler og deres anvendelse som prostaglandin D2-reseptorantagonister
JP2011519845A5
(enExample )
2012-06-21
CA2680636A1
(en )
2008-10-09
Quinoline derivatives as crth2 receptor ligands
JP2017509611A5
(enExample )
2018-03-29
MY145648A
(en )
2012-03-15
Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist
DK2046787T3
(da )
2011-07-18
Pyrazolo[3,4-B]pyridin-forbindelser, og deres anvendelse som PDE4-inhibitorer
WO1999000388A1
(en )
1999-01-07
Novel naphthyridine derivatives or salts thereof
JP2004536851A
(ja )
2004-12-09
Nk−1受容体アンタゴニスト活性を有するピペラジンオキシム誘導体
WO2006085212A3
(en )
2006-10-19
Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
JP2003519146A
(ja )
2003-06-17
痛みの処置のための方法および組成物
EA200701879A1
(ru )
2008-02-28
Замещённые производные оксадиазаспиро [5.5] ундеканона и их применение в качестве антагонистов нейрокинина